SCMOM 2012_ViaCyte – Video

Posted: November 30, 2012 at 12:42 pm




SCMOM 2012_ViaCyte
ViaCyte, Inc., a leader in the emerging field of regenerative medicine, is headquartered in San Diego, California. ViaCyte #39;s innovative product is based on the differentiation of stem cells into pancreatic beta cell precursors (PEC-01), with subcutaneous implantation in a retrievable and immune-isolating encapsulation medical device. Once implanted, the precursor cells mature into endocrine cells that secrete insulin in a regulated manner to control blood glucose levels. ViaCyte #39;s goal is a product that can free Type 1 and 2 diabetic patients from long-term insulin dependence. ViaCyte has received substantial financial support from both CIRM and JDRF. http://www.viacyte.com Presenter: Paul Laikind, President and CEO, ViaCyteFrom:AllianceRegenMedViews:5 1ratingsTime:16:42More inScience Technology

Visit link:
SCMOM 2012_ViaCyte - Video

Related Posts

Comments are closed.

Archives